SCHEMBL27759918

SCHEMBL27759918

CC1CN(c2ccncc2)CCN1C=O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.42
▸ CHKA P35790 1/20 0.42
▸ ADRB2 P07550 1/20 0.39
▸ NCF1 P14598 1/20 0.39
▸ PLD1 Q13393 1/20 0.39
▸ GRM1 Q13255 2/20 0.38
▸ CYP2D6 P10635 4/20 0.36
▸ CYP2C9 P11712 3/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ HTR7 P34969 1/20 0.36
▸ SMO Q99835 1/20 0.36
▸ HIF1A Q16665 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CHRM1 P11229 1/20 0.34
▸ EED O75530 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19049368 0.84 NOTUM (0.42) GSK3BCYP2D6TSHRMAPTHTT
SCHEMBL13715624 0.84 NOTUM (0.42) GSK3BCYP2D6TSHRMAPTHTT
SCHEMBL27781453 0.84 GRM1 (0.52) GSK3BGRM1
SCHEMBL28956406 0.81 ALDH1A1 (0.42) HTR7MAPTHTTSMN1; SMN2
SCHEMBL14473329 0.79 ALDH1A1 (0.34) —
SCHEMBL27702488 0.75 GRM1 (0.54) GSK3BPLD1GRM1CYP2D6TSHR
SCHEMBL27714917 0.73 GCKR (0.46) GSK3BCHKAGRM1CYP2D6CYP2C9
SCHEMBL27930045 0.72 MAPT (0.53) GSK3BCHKACYP2D6TSHRMAPT
SCHEMBL4354268 0.72 TRPV1 (0.50) —
SCHEMBL2383849 0.71 CHKA (0.57) CHKAADRB2NCF1PLD1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101501035-B Pyrimidine derivatives as PI3K inhibitors and uses thereof CHUGAI PHARMACEUTICAL CO LTD 2013-01-23 — — CN disclosed
CN-101501035-A Pyrimidine derivatives as P13K inhibitors and uses thereof CHUGAI PHARMACEUTICAL CO LTD (JP) 2009-08-05 — — CN disclosed
Send feedback